MRS2 and cancer: A different model, designed to predict cancer or preneoplasia vs. healthy or gastritis, yielded an even higher mAUROC of 83.9% (73.9–93.9% (95% CI)) and was based on the plasma concentrations of ARG1, HPT, CA2, MAN2A1, and LBP.